BIOPHARM FORWARD ApS: Financial statements 2021
CVR: 32438784
Source: annual report 2021, Danish Business Authority
26/08/2020 – 25/08/2021
BIOPHARM FORWARD ApS (CVR 32438784) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK 928,008 and a net result of DKK 1,456,847 compared with DKK 145,891 the year before. That is an increase of 410.2% compared with the year before. Equity in the 2021 report amounted to DKK 1,552,967. The solvency ratio was 86.8%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 928,008
- Profit/Loss
- DKK 1,456,847
- Equity
- DKK 1,552,967
- Total Assets
- DKK 1,788,398
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | - | 928 t. | 1.5 mio. | 1.6 mio. | 1 |
| 2020 | - | 182 t. | 146 t. | 209 t. | 1 |
| 2019 | - | 291 t. | 201 t. | 171 t. | 0 |
| 2018 | - | -2 t. | -2 t. | -30 t. | - |
| 2017 | - | -2 t. | -2 t. | -28 t. | - |
Official annual report
Find more companies like BIOPHARM FORWARD ApS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2021
BIOPHARM FORWARD ApS has published its annual report for 2020. Gross profit came to DKK 181,875, and the net result was DKK 145,891.
About BIOPHARM FORWARD ApS
BIOPHARM FORWARD ApS is a Danish company of the type Anpartsselskab based in Espergærde, founded in 2009. The company is registered under the industry Andre liberale, videnskabelige og tekniske tjenesteydelser i.a.n.. The management consists of Jonas Hink. The company is owned by Jonas Hink. The company has 1 employee (2025). In 2025, the company reported a gross profit of DKK 997,234 and a net result of DKK 243,660 compared with DKK 385,061 the year before. Equity in the 2025 report amounted to DKK 1,741,315.